{"name":"Emergent BioSolutions","slug":"emergent-biosolutions","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":14,"colorKey":"oncology","drugs":[{"name":"AV7909 Formulation 1","genericName":"AV7909 Formulation 1","slug":"av7909-formulation-1","indication":"Other","status":"phase_1"},{"name":"AV7909 Formulation 2","genericName":"AV7909 Formulation 2","slug":"av7909-formulation-2","indication":"Other","status":"phase_1"},{"name":"CYFENDUS","genericName":"CYFENDUS","slug":"cyfendus","indication":"Other","status":"marketed"},{"name":"ACAM2000","genericName":"ACAM2000","slug":"acam2000","indication":"Other","status":"marketed"},{"name":"ACAM2000 Smallpox Vaccine","genericName":"ACAM2000 Smallpox Vaccine","slug":"acam2000-smallpox-vaccine","indication":"Prevention of smallpox","status":"phase_2"},{"name":"AIGIV","genericName":"AIGIV","slug":"aigiv","indication":"Other","status":"phase_2"},{"name":"AV7909 Formulation 3","genericName":"AV7909 Formulation 3","slug":"av7909-formulation-3","indication":"Other","status":"phase_1"},{"name":"AV7909 Formulation 4","genericName":"AV7909 Formulation 4","slug":"av7909-formulation-4","indication":"Other","status":"phase_1"},{"name":"Ad4-PA-1","genericName":"Ad4-PA-1","slug":"ad4-pa-1","indication":"Other","status":"phase_1"},{"name":"Ad4-PA-GPI-1","genericName":"Ad4-PA-GPI-1","slug":"ad4-pa-gpi-1","indication":"Other","status":"phase_1"},{"name":"Blood sample collection","genericName":"Blood sample collection","slug":"blood-sample-collection","indication":"Other","status":"marketed"},{"name":"Sample Collection","genericName":"Sample Collection","slug":"sample-collection","indication":"Other","status":"marketed"},{"name":"UV-4B 10 mg","genericName":"UV-4B 10 mg","slug":"uv-4b-10-mg","indication":"Other","status":"phase_1"},{"name":"Vaccination with ACAM2000","genericName":"Vaccination with ACAM2000","slug":"vaccination-with-acam2000","indication":"Other","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"AVA","genericName":"AVA","slug":"ava","indication":"Prophylaxis of anthrax infection in persons at high risk of exposure","status":"marketed"}]}],"pipeline":[{"name":"AV7909 Formulation 1","genericName":"AV7909 Formulation 1","slug":"av7909-formulation-1","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"AV7909 Formulation 2","genericName":"AV7909 Formulation 2","slug":"av7909-formulation-2","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"AVA","genericName":"AVA","slug":"ava","phase":"marketed","mechanism":"AVA is an anthrax vaccine that stimulates the immune system to produce antibodies against anthrax toxins, providing protection against infection by Bacillus anthracis.","indications":["Prophylaxis of anthrax infection in persons at high risk of exposure","Post-exposure prophylaxis following confirmed or suspected anthrax exposure"],"catalyst":""},{"name":"CYFENDUS","genericName":"CYFENDUS","slug":"cyfendus","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ACAM2000","genericName":"ACAM2000","slug":"acam2000","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"ACAM2000 Smallpox Vaccine","genericName":"ACAM2000 Smallpox Vaccine","slug":"acam2000-smallpox-vaccine","phase":"phase_2","mechanism":"ACAM2000 Smallpox Vaccine works by stimulating an immune response to the smallpox virus.","indications":["Prevention of smallpox"],"catalyst":""},{"name":"AIGIV","genericName":"AIGIV","slug":"aigiv","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"AV7909 Formulation 3","genericName":"AV7909 Formulation 3","slug":"av7909-formulation-3","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"AV7909 Formulation 4","genericName":"AV7909 Formulation 4","slug":"av7909-formulation-4","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Ad4-PA-1","genericName":"Ad4-PA-1","slug":"ad4-pa-1","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Ad4-PA-GPI-1","genericName":"Ad4-PA-GPI-1","slug":"ad4-pa-gpi-1","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Blood sample collection","genericName":"Blood sample collection","slug":"blood-sample-collection","phase":"marketed","mechanism":"Blood sample collection is a diagnostic procedure, not a drug with a pharmacological mechanism of action.","indications":[],"catalyst":""},{"name":"Sample Collection","genericName":"Sample Collection","slug":"sample-collection","phase":"marketed","mechanism":"Sample Collection is not a drug but a process used in clinical trials and medical testing to gather biological samples for analysis.","indications":[],"catalyst":""},{"name":"UV-4B 10 mg","genericName":"UV-4B 10 mg","slug":"uv-4b-10-mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Vaccination with ACAM2000","genericName":"Vaccination with ACAM2000","slug":"vaccination-with-acam2000","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNUEptUUg1blZLdE5ITVZ1ZXFPTmFFQUpSMWJDRmY1amhSeG04emhkZHZrS1JQWEV4TmxwWk1MYnF4YXNvR0hjeklJMWNFbjh1cVgxOWUzR3ZoT0dhaGZpbzB2N1MxcWd5QS1UbjBwSm01cTROdEhyVWNRT1FlT0UzU19NTjAyLXVOdDEzbmVJV1Z4MVRkX21QSDVpYUJPNWpJ?oc=5","date":"2026-01-16","type":"pipeline","source":"Fierce Pharma","summary":"Former Emergent CEO Kramer faces insider trading allegations in NY - Fierce Pharma","headline":"Former Emergent CEO Kramer faces insider trading allegations in NY","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNRXBBTy12eWZjQlFSbkNMZ2l0dGJ4WDdLOGNScWlWVVBrMk1NUXU2WDFheWt4alVtcTJpVER2SWpQZWk3eHREWkpyQVdjWURsNmRrNzJGaVBMY29hMTEzR2xuN0NsMFlOdHpTNG9takFjYU51WHd5VjJtbG96OFNxaE42cV9vZVNyM0NBRFQyTC10dU5aSnRGQl8tN1ZJQkhMNVhUNDZjMA?oc=5","date":"2025-06-26","type":"pipeline","source":"Fierce Pharma","summary":"Emergent lands $62.4M upgrade to botulism antitoxin supply pact with US - Fierce Pharma","headline":"Emergent lands $62.4M upgrade to botulism antitoxin supply pact with US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPUWwtQWlFbmZHUFk1YXJTNmpuUGRYdkJjSUNMM1NhV1JPVWwwQ3dhYlp5NVY2QWZDbFdHVHFPcFl2QVdDaXB2M0xQeXhHSGRvN1ZISHVzYUFLT0IzWkVJTFNYUXc3azZYNkpfSGVocUpHM1pPOW5BQkItSkVKNU9iZ0RmYzF1aUpZbVBRZ2twUU1maDhLVUxuVmcyMHFOemx6UUJZN3RNU01Hc1dNOEtQdFpmeTU?oc=5","date":"2025-03-10","type":"pipeline","source":"Fierce Pharma","summary":"Indian contractor Syngene throws down $37M for Emergent's Baltimore biologics plant - Fierce Pharma","headline":"Indian contractor Syngene throws down $37M for Emergent's Baltimore biologics plant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPWEpheWF6ck1XT2JNZGpBSnBYdURZNVhuZ3RHcHRsVUdqWVEwRjEzc0s1cVp2Qk1xbkd5NnBGbUlvOXA1a3pldkxSVEV3Z1RaUERyRm9vWC1lWDRLcDVxX0x2SUQtWTltbUQ5dkNhVm1EZUh0bUFsWGRkcno3RFB3V0R1UFBUX1RONXFNd3BsQThCVmhpbUFZVGRrVGROaG5rVnVGWU13V0tSQ3RYbnJoenVscWZRaDlnNlhKNVE1amFoUQ?oc=5","date":"2025-01-15","type":"deal","source":"Fierce Pharma","summary":"JPM25: Emergent secures licensing deal for opioid overdose spray amid recovery plan - Fierce Pharma","headline":"JPM25: Emergent secures licensing deal for opioid overdose spray amid recovery plan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPd244aGU2OERReVJxUlBpWVJhSGdvaXRpVlhHZzhuNDloSXcwUGpUWS01WjlRVUYyX1lYSXJhcmV1VTlJWGJTN0VybEF6elF0SlNaR3RDRUlPTnNGWE9iUFY1ZVExTTBneDlydWxMRGRCN0lXWWNHOEVvbnRVVUVJQzBUcVJqWWNibXhUUlc2VzhuZzdVVUUyenNKZThLVjBybE0wY0taWnV6UzVQSWttQlp4LTF3bUVMZTJxa29Ma0d1THRYU2c?oc=5","date":"2024-08-21","type":"pipeline","source":"Pharmaceutical Technology","summary":"Emergent BioSolutions finalises manufacturing site sale to Bora Pharmaceuticals - Pharmaceutical Technology","headline":"Emergent BioSolutions finalises manufacturing site sale to Bora Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPNTFMNnZreW5fdmhyTDh6T1VfVjQ0RE1ZcjA4SVlYZkc4TjNQcncxMW9MdlpsRVFfVER3MHpQOUZPR1I4RWVRYndqR2xjcXlUY1YxUFNJdWNkQV9yWGsyTG1TeGRfT1pDSDhMdndWcjR2ZmF1LW9wdUc4Rk8zRndCeTJmUzU1V2FrbHlBUzJtR0hST1d3R1I1VWVsLU4tTWZNNHREOUdpbkVHa0hUWW5tRXRiODdGamYySnBNSlZNTFRLRkk?oc=5","date":"2024-07-02","type":"pipeline","source":"Fierce Pharma","summary":"Emergent BioSolutions bags $250M in contract modifications to help boost US supply of medical countermeasures - Fierce Pharma","headline":"Emergent BioSolutions bags $250M in contract modifications to help boost US supply of medical countermeasures","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQYzRLbGhMVmRCckt0emI3akpkUUtnb3VfcnJ2dG9mcEoyVEt4SENnT01iMW5MSERtenN2ZE9vaUd5dGxDcnJ0aGZ3eGV6MlljTGRuMThXLXNUN1RxXzMya01MOWQzSjcwcW1uanVKTkhncnBET1BFTWhEdnFndUs1OU1VODJ2UEUwb0ZfR2QtclhfT0RLSjhvRkgxV1Y1ZG50Tlp2eHJqeXpWM0lMSllNQnhORm4zc1gwc1ZfeHRxYw?oc=5","date":"2024-06-26","type":"deal","source":"Manufacturing Dive","summary":"Bora Pharmaceuticals acquires Emergent Biosolutions’ Maryland facility - Manufacturing Dive","headline":"Bora Pharmaceuticals acquires Emergent Biosolutions’ Maryland facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOMER3REVVUnBXNE5WMkh3S0t2VHdWVzA0T2dCTUhWdE9aNjczZFcxeFRmTnM0cTVQTVJsZFk5cHJZSy1HZnU2aVNRZVNNdlc4RW51T1EtZnVUTWdUS0xnaGlPa2x4VG5zOWNTZGtCYkU2WFdxZ2NxbEo5LXRmbzJFZ2JWMzJwSm5WcjRBVkZNVFltNXJzYnpubUJ4Q0VEX0NqMVEzWDZRYmJULWcxRXJ2OUNR?oc=5","date":"2024-06-20","type":"pipeline","source":"Fierce Pharma","summary":"Emergent, pivoting away from CDMO business, sells Baltimore plant to acquisitive Bora for $30M - Fierce Pharma","headline":"Emergent, pivoting away from CDMO business, sells Baltimore plant to acquisitive Bora for $30M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPNV85NTYwb2U2ZWVkRloyTExjMnFOdWxCQUV4R3JwVWRMc0d2RXZBNWhPMjlkaHpKdDhGT3REY0ZaSWdKOXpLb1NSaXl4MWVBS2tLSExwaWZldGUtaXM3VmlqQUxhVkEwdmV5aUlESV9wb0ZpdE5vV3JqTTE5dzJxWFpvXy1lak14ODdCeEdsYWpGMy1MejU3QjNhdjdpR2owb0ZvZV9YanFlQ3BjNDRzcUIwSGtHWG5Dcmc?oc=5","date":"2024-05-07","type":"pipeline","source":"Manufacturing Dive","summary":"Emergent Biosolutions to shutter 2 Maryland facilities, lay off 300 - Manufacturing Dive","headline":"Emergent Biosolutions to shutter 2 Maryland facilities, lay off 300","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNakRMY1ZIdWFWZXdjVTdGSFRKalJtcXpTUklzWlpFM2phVXhFTzVjUFg4ZUFGUUR3QjlnekdQemZWaV9tR0l6ZzkyVWpuQTRMUUtNYWNYV1FwNnBIdUwyQ3FSLVByeFg1TG5jNzMxTWdIU1VYWVlZLXVYMU84dHQ0R29FTVg3MnB5djJYLWtlWmp6UzN1ZUlWeGZBLVRKRlNrcWl5NkFXQ3hEU1VFXzY0aFZHUEdJNkF2ZzJhLUZlNnVITnM?oc=5","date":"2024-05-01","type":"pipeline","source":"Fierce Pharma","summary":"Emergent BioSolutions to cut 300 employees, shutter 2 facilities in restructuring launched under new CEO - Fierce Pharma","headline":"Emergent BioSolutions to cut 300 employees, shutter 2 facilities in restructuring launched under new CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNSTJsbU41RkZzTThCcl9zMHlRdExheHpFdm5FMTNDRmNQdFp5WFFzaWdlRWlvczA2Y25vV01wTWdtaHJja3FNMDFuR1RUaENqY2k5NzVFQzNsMHhiX2JRdm43NEFQSU4yYUZBN2xSLWNFdTdTME9NWVFIdXRiZXI2aFNmYWNOTnc5aEg3ODBaM3RiUzFtWGhMQjgyN21Yc0I5UVE?oc=5","date":"2023-02-08","type":"pipeline","source":"Contract Pharma","summary":"Emergent BioSolutions Announces Organizational Changes - Contract Pharma","headline":"Emergent BioSolutions Announces Organizational Changes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQS1o1ODJ2VmU1SDBhRk5rNy1zTDB3Ri1xODVWQTQ0YlZXeDkzRVJiQURnZ3duRnZtVVQtTTNabnhnRFZTcnJjT1d5OWQ2cTRsWGZGLWpfcl9sT0xoWTNhX1VrT0dOQzBhX3VEX00wMTBBRUNTdW1aN25wWlk3Z0FRQXA0Z3lzU0FpaU5kdm5XNWNvSXFZNjhUaw?oc=5","date":"2018-08-29","type":"deal","source":"BioSpace","summary":"Emergent BioSolutions Acquires Adapt Pharma in $735 Million Deal - BioSpace","headline":"Emergent BioSolutions Acquires Adapt Pharma in $735 Million Deal","sentiment":"neutral"}],"patents":[],"drugCount":15,"phaseCounts":{"phase_1":7,"marketed":6,"phase_2":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}